Preparation of endothelin antagonist ABT-627Steven J. Wittenberger; Maureen A. McLaughlin · 1999

ChemInform Abstract: Preparation of Endothelin Antagonist ABT-627.Steven J. Wittenberger; Maureen A. McLaughlin · 1999

Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: <i>in vitro</i> studiesWU-WONG, J. Ruth; DIXON, Douglas B.; CHIOU, William J.; SORENSEN, Brian K.; LIU, Gang; JAE, H.-S.; TASKER, Andrew; GELDERN, Thomas W. Von; WINN, Martin; OPGENORTH, Terry J. · Clinical Science · 2002

Pharmacology of endothelin receptor antagonists ABT-627, ABT-546, A-182086 and A-192621: <i>ex vivo</i> and <i>in vivo</i> studiesWESSALE, Jerry L.; ADLER, Andrew L.; NOVOSAD, Eugene I.; CALZADILLA, Samuel V.; DAYTON, Brian D.; MARSH, Kennan C.; WINN, Martin; JAE, Hwan-Soo; GELDERN, Thomas W.von; OPGENORTH, Terry J.; WU-WONG, J. Ruth · Clinical Science · 2002

Enantioselective Synthesis of the Pyrrolidine Core of Endothelin Antagonist ABT-627 (Atrasentan) via 1,2-OxazinesMonika Buchholz; Hans-Ulrich Reißig · 2003

‘Irreversible’ Endothelin-1 Binding Does Not Prohibit ABT-627 From Reversing Endothelin-1-Induced EffectsChiou, William J.; Wessale, Jerry L.; Geldern, Thomas von; Opgenorth, Terry J.; Wu-Wong, Jinshyun R. · Journal of Cardiovascular Pharmacology · 2000

‘Irreversible’ Endothelin-1 Binding Does Not Prohibit ABT-627 From Reversing Endothelin-1-Induced EffectsChiou, William J.; Wessale, Jerry L.; Geldern, Thomas von; Opgenorth, Terry J.; Wu-Wong, Jinshyun R. · Journal of Cardiovascular Pharmacology · 2000

Neramexane&NA; · Drugs in R & D · 2002

Acknowledgement to RefereesAnton van Rensburg · Drugs in R&D · 2013

Etravirine&NA;, · Drugs in R & D · 2006

Transplant RejectionStephen G. Coleman,Richelle Paterson · Drugs in R&D · 1999

BTI 322Drugs in R&D · 1999

Campath-1GDrugs in R&D · 1999

CHH 380Drugs in R&D · 1999

EtanerceptDrugs in R&D · 1999